$MODD

Modular Medical, Inc. (MODD): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Modular Medical, Inc. (MODD) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 25, 2026, Jeffrey Goldberg provided written notice to the chair of the nominating and governance committee (th

Original reporting
Published Sep 29, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 29, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$MODD
Neutral
high confidence
Mentioned
$MODD
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MODDNeutralLow
01

Why it matters

The filing is a routine corporate governance update with limited market impact.

02

Market read

A standard director turnover filing; unlikely to move the stock significantly.

03

What to watch

Potential appointment of new directors with different expertise may influence future R&D direction.

Relevance 6/10Novelty 2/10Timing: after filing today

Background

Modular Medical Inc. filed an 8‑K announcing two board members will not seek re‑election at the upcoming annual meeting.

Company-level read

Ticker impact

$MODDNeutralHigh confidence
Context

SEC Form 8‑K reports directors Jeffrey Goldberg and Carmen Volkart will not stand for re‑election, indicating upcoming board turnover.

Expected impact

potential slight pressure as investors price in board turnover uncertainty

Evidence & confidence

No operational or financial changes disclosed; market typically reacts modestly to non‑material governance updates.

Market effects

Minimal impact on the medical device sector; governance change does not alter industry dynamics.

Negligible effect on U.S. markets; only a micro‑cap stock is affected.

None

Counterpoint

If the departing directors were key strategic advocates, their exit could signal upcoming strategic shifts.

Key entities

  • Modular Medical, Inc.

    US‑listed medical device company (ticker MODD).

  • Jeffrey Goldberg

    Current board member stepping down.

  • Carmen Volkart

    Current board member stepping down.

Related articles

$MODDHigh

Modular Medical stock rises after securing PBM contract

Modular Medical Inc (MODD) shares rose 2.3% after securing a contract with a national U.S. pharmacy benefit manager, making its Pivot insulin delivery system available through the PBM. The company aims to broaden patient access to its Pivot tubeless patch pump, a wearable insulin delivery platform for diabetes management.

$UPCMed

6 After-Hours Healthcare Gainers: Universe Pharma, BioAffinity, Modular Medical, Telix Pharma & More

Universe Pharmaceuticals (UPC) rose 34.89% after-hours due to multiple Schedule 13G filings. BioAffinity (BIAF) explores new uses for its CyPath Lung test, up 3%. Modular Medical (MODD) gained 7% after announcing a product launch. MAIA (MAIA) rose 6% following an insider purchase. Telix (TLX) completed a Phase 3 study, up 2.21%. aTyr Pharma (ATYR) awaits FDA response, up 4%.